Results 251 to 260 of about 90,498 (305)

Blockade of endothelin receptors mitigates SARS-CoV-2-induced osteoarthritis

Man Ting Au, Junguo Ni, Kaiming Tang, Wei Wang, Lanlan Zhang, Hantang Wang, Fangyi Zhao, Zhan Li, Peng Luo, Lawrence Chun‐Man Lau, PK Chan, Cuiting Luo, Bo Zhou, Lin Zhu, Charlie Yuli Zhang, Tianshu Jiang, Marianne Lauwers, Jasper Fuk‐Woo Chan, Shuofeng Yuan, Chunyi Wen   +19 more
openalex   +2 more sources

Endothelin antagonists for hypertension: has their time finally arrived? [PDF]

Clin Sci (Lond)
Schiffrin EL.
europepmc   +1 more source

Dysregulation of MMP-2 and MMP-9 in Post-COVID-19 and IPF: Correlations with Systemic Inflammation and Endothelial Dysfunction. [PDF]

J Clin Med
Balan OV, Malysheva IE, Tikhonovich EL, Lysenko LA.   +3 more
europepmc   +1 more source

Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan. [PDF]

J Comp Eff Res
Ngai C, Patel M, Kopiec A, Fu S, Hummel N.   +4 more
europepmc   +1 more source

The effects of time-restricted eating combined with Tai Chi on glycolipid metabolism and endothelial function in postmenopausal women. [PDF]

J Int Soc Sports Nutr
Wang XY, Chen J, Li H.
europepmc   +1 more source

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Current Therapeutic Strategies and Future Prospects. [PDF]

Biomolecules
Yokoyama YM, Watanabe R, Yamaguchi T, Ishihara R, Shiomi M, Fujita Y, Katsushima M, Fukumoto K, Haji Y, Yamada S, Hashimoto M.   +10 more
europepmc   +1 more source

Correction to: The dual endothelin-1 antagonist aprocitentan alleviates mitochondrial oxidative stress in human cardiac fibroblasts. [PDF]

Eur Heart J Cardiovasc Pharmacother
europepmc   +1 more source